Friday, April 25, 2014
FAIRFIELD-SUISUN, CALIFORNIA
99 CENTS

Pfizer disputes suit claiming Zoloft doesn’t work

TRENTON, N.J. — The maker of Zoloft is being sued in an unusual case alleging the popular antidepressant has no more benefit than a dummy pill and that patients who took it should be reimbursed for their costs.

Zoloft’s maker, Pfizer Inc., the world’s biggest drugmaker by revenue, disputes the claim, telling The Associated Press Thursday that clinical studies and the experience of millions of patients and their doctors over two decades prove Zoloft is effective.

The lawsuit was described as frivolous by Pfizer and four psychiatry experts interviewed by The AP.

Not so, according to plaintiff Laura A. Plumlee, who says Zoloft didn’t help her during three years of treatment. Her attorney, R. Brent Wisner of the Los Angeles firm Baum Hedlund Aristei Goldman, argues the Food and Drug Administration shouldn’t have approved Zoloft because Pfizer didn’t publish some clinical studies that found the drug about as effective as a placebo.

“It’s about Pfizer deliberately withholding this information from consumers and then advertising this drug as very effective,” Wisner said.

The suit accuses Pfizer of consumer fraud and other offenses, including quietly paying prominent doctors to tout Zoloft to colleagues or to be listed as authors of positive medical journal articles the company prepared for publication. New York-based Pfizer did not specifically respond to those allegations.

“Pfizer believes the lawsuit filed in California is groundless and is based largely on information … that has been widely criticized by many experts in the mental health field,” the company said in a statement provided to The AP. It said the FDA approved Zoloft in 1991 after reviewing “efficacy and safety data from more than 20 clinical studies involving more than 5,000 patients.”

The president-elect of the American Psychiatric Association, Dr. Jeffrey Lieberman, said the lawsuit’s claims are “ridiculous” and without merit.

“As a class, antidepressant medications are highly effective. They alleviate substantial amounts, if not complete symptoms, in 50 to as high as 80 percent of patients treated who suffer from major depression,” Lieberman said.

He stressed the medicines must be given at the proper dose, usually for several weeks to months, to get the full benefit. Also, patients should not stop taking any antidepressant without consulting their doctor.

Dr. Norman Sussman, a New York University psychiatry professor, said for any given patient, there’s only about a 35 percent chance a particular antidepressant will help.

Patients may have to try a few to find one that works for them, due to differences in patients’ brains and the structure of the drug molecules.

Also, antidepressants tend to help severely depressed patients far more than people with mild depression or those who are temporarily blue from troubles such as a relative dying, rather than chemical imbalances in the brain.

The lawsuit, filed Wednesday in federal court in San Jose, Calif., asks a judge to approve two class-action cases, one for California residents who took Zoloft and one for all U.S. users.

It asks the judge to order Pfizer to correct “misleading” information in Zoloft’s package insert and refund everything California patients paid for Zoloft. Consumer fraud laws differ from state to state, so if Wisner wins the case, he said he’ll likely sue in other states.

Two law school professors, Benjamin Zipursky at Fordham University and Carl Tobias of the University of Richmond, said Plumlee’s suit might end up being dismissed based on a decade-old Supreme Court ruling that plaintiffs can’t recover alleged damages by claiming a company defrauded the FDA to get a drug approved. Zipursky said the lawsuit stresses that consumers were harmed financially, so it could get approved as a class action.

“Federal courts have taken different views as to . . . whether you can use a federal lawsuit to second-guess the FDA,” he added.

Drugmakers frequently are sued by patients claiming a medicine harmed them and lawyers alleging companies hid medicine risks from the public. Federal and state prosecutors regularly sue drugmakers for overcharging government health programs, marketing drugs for unapproved uses and other criminal or civil offenses.

But a lawsuit claiming a drug doesn’t work, so patients should get their money back, might be a first, experts said.

The case also is unusual because Zoloft has had cheap generic competition since 2006, so it’s no longer advertised, and little brand-name Zoloft is sold.

The lawsuit opens a window into the ongoing debate about just how effective and safe the many newer-generation antidepressants are – drugs including the huge blockbusters Zoloft, Prozac, Paxil and Effexor.

These medicines, approved starting in the late 1980s, were thought to have less-dangerous side effects than early antidepressants. Over time, the newer antidepressants were increasingly prescribed by primary care doctors, not just psychiatrists.

Pharmaceutical companies marketed the drugs heavily, with very-positive ads targeting consumers. Millions, many with just mild or temporary depression, asked their family doctor for a prescription. Sales grew steadily, declined for several years when the drugs were linked to suicidal thoughts, then rose again the last few years.

Today, antidepressants are the ninth-most popular type of prescription medicine, with annual sales topping $20 billion worldwide, according to health data firm IMS Health.

Plumlee, 49, said in an exclusive interview that she took Zoloft from 2005 through 2008, while her doctor repeatedly increased the dose. He “swore it was working,” but she felt it didn’t help. Frustrated, and having gained 50 pounds as a side effect, the Watsonville, Calif., homemaker and mother of two teenagers quit Zoloft cold turkey and was hospitalized for six days with flu-like withdrawal symptoms.

“I kind of had a breakdown,” she said. “I just felt like I couldn’t hope.”

Four years later, Plumlee saw a “60 Minutes” news program in which the key expert witness since hired for her case, Irving Kirsch, said his research on antidepressants indicated most improvement in depressed patients was from the placebo effect. That’s the benefit most patients get from believing a medicine works and from having doctors and nurses caring for them.

Kirsch, associate director of Harvard Medical School’s Program in Placebo Studies, has published a book and several medical journal articles on the effect. With colleagues, he reviewed numerous studies of popular antidepressants, including unpublished studies obtained using the Freedom of Information Act.

“The difference between drug and placebo is very small,” below the level that benefits patients, Kirsch concluded.

He said Pfizer produced two studies showing Zoloft worked better than placebo — the FDA’s requirement for approval — but most Zoloft studies showed its effect was the same as a placebo.

The Associated Press

The Associated Press

LEAVE A COMMENT

Discussion | No comments

The Daily Republic does not necessarily condone the comments here, nor does it review every post. Read our full policy

.

Solano News

Concert master gets solo during Solano Symphony shows

By Amy Maginnis-Honey | From Page: B1

 
So, where is that editor?

By Susan Winlow | From Page: B1

Suisun break ground on Walmart

By Barry Eberling | From Page: A1 | Gallery

 
District attorney candidates field questions at forum

By Jess Sullivan | From Page: A1 | Gallery

Open Studios May 3-4 in Benicia

By Amy Maginnis-Honey | From Page: B1 | Gallery

 
‘Tonight Show’ comic stops in Vallejo

By Amy Maginnis-Honey | From Page: B1

The spy who went to Armijo High

By Tony Wade | From Page: A2

 
Cheating Daylight kicks off tour in hometown

By Amy Maginnis-Honey | From Page: B2

Little Anthony joins line up at county fair

By Amy Maginnis-Honey | From Page: B2

 
Notable Benicia homes, colorful gardens open for tour

By Amy Maginnis-Honey | From Page: B2

Daily Republic seeks good news for column

By Daily Republic staff | From Page: A3, 5 Comments

 
Sutter’s thank-you to children gets top marks

By Ryan McCarthy | From Page: A3 | Gallery

Suisun Marsh plan gets federal signoff

By Barry Eberling | From Page: A3

 
Vacaville police promote 3 from within

By Susan Winlow | From Page: A3 | Gallery

Machete-attack case goes to jury

By Jess Sullivan | From Page: A3

 
Tickets on sale for Denim and Diamonds fundraiser

By Amy Maginnis-Honey | From Page: A4

 
Spring book sales at Vacaville, Vallejo libraries

By Amy Maginnis-Honey | From Page: A4

Children battle in Suisun – using book knowledge

By Susan Hiland | From Page: A4 | Gallery

 
Library fundraiser ‘BrewHaha’ on tap May 3

By Amy Maginnis-Honey | From Page: A5

 
Brown reappoints Vacaville man to post

By Barry Eberling | From Page: A5

Community meeting on Fairfield crime set

By Ryan McCarthy | From Page: A5, 1 Comment

 
Fairfield police log: April 23, 2014

By Susan Hiland | From Page: A12

 
Suisun City police log: April 23, 2014

By Susan Hiland | From Page: A12

Weather for Friday, April 25, 2014

By Daily Republic staff | From Page: B12

 
.

US / World

Chicago doctor among those killed in Afghanistan

By The Associated Press | From Page: A1

 
Water picture improves for some California towns

By The Associated Press | From Page: A1

Study links California drought to global warming

By The Associated Press | From Page: A1

 
Gunman kills 3 Americans at Kabul hospital

By The Associated Press | From Page: A1

Bill calls for enhanced lessons on Obama election

By The Associated Press | From Page: A5

 
100-year-old California woman gets diploma

By The Associated Press | From Page: A5

California bill attacks growing corporate wage gap

By The Associated Press | From Page: A5

 
NRA seeks universal gun law at national meeting

By The Associated Press | From Page: A6 | Gallery

Senate report criticizes former DHS watchdog

By The Associated Press | From Page: A7

 
Measles off to a fast start, as cases trend up

By The Associated Press | From Page: A7

Nevada rancher defends remarks, loses supporters

By The Associated Press | From Page: A7

 
Management, safety cited for radiation release

By The Associated Press | From Page: A7

Gaga over gorillas? 2 babies arrive at Bronx Zoo

By The Associated Press | From Page: A7 | Gallery

 
Senate’s newest class speaks out on foreign policy

By The Associated Press | From Page: A7

Tiny Pacific nation sues 9 nuclear-armed powers

By The Associated Press | From Page: A7

 
Everest climbing season in disarray after deaths

By The Associated Press | From Page: A10

Vatican: Pope’s private calls don’t reflect policy

By The Associated Press | From Page: A10

 
Families of ferry’s lost confront SKorea officials

By The Associated Press | From Page: A10

Israel halts peace talks with Palestinians

By The Associated Press | From Page: A10 | Gallery

 
Ukraine moves against insurgents in the east

By The Associated Press | From Page: A10 | Gallery

Costa Rica is demanding US explain ‘Cuban Twitter’

By The Associated Press | From Page: A10

 
FDA eases into regulating e-cigarettes

By The Associated Press | From Page: B11

FDA OKs first-ever DNA alternative to Pap smear

By The Associated Press | From Page: B11

 
Postal workers’ unions protest Staples program

By The Associated Press | From Page: B11

11 kids, driver hurt in Calif. school bus crash

By The Associated Press | From Page: A12

 
.

Opinion

 
Editorial cartoons for April 25, 2014

By Daily Republic Syndicated Content | From Page: A11

Some diet news is tough to digest

By Bud Stevenson | From Page: A11

 
Has the militia movement re-emerged in American life?

By Ben Boychuk and Joel Mathis | From Page: A11

 
Easily swayed voters on both sides

By Letter to the Editor | From Page: A11, 3 Comments

.

Living

Community Calendar: April 25, 2014

By Susan Hiland | From Page: A2

 
Today in History for April 25, 2014

By The Associated Press | From Page: A2

Horoscopes for April 25, 2014

By Holiday Mathis | From Page: A9

 
How can I renew my friendship with Ellie without looking desperate?

By Kathy Mitchell and Marcy Sugar | From Page: A9

.

Entertainment

Week in preview April 25-May 1, 2014

By Amy Maginnis-Honey | From Page: B1

 
Review: Walker memorable in gritty ‘Mansions’

By The Associated Press | From Page: B3

 
Review: ‘Quiet Ones’ is more creaky than creepy

By The Associated Press | From Page: B3

Entertainment calendar April 25, 2014

By Susan Hiland | From Page: B4

 
TVGrid

By Daily Republic Syndicated Content | From Page: B6

.

Sports

Donaldson, Kazmir lead A’s past Astros 10-1

By The Associated Press | From Page: B7 | Gallery

 
Solano sweeps all-BVC softball postseason awards

By Paul Farmer | From Page: B7

Fishing: Bass Reapers to hold Berryessa tournament

By Daily Republic staff | From Page: B7

 
Prep girls soccer: Vanden slips past AC for 3-2 SCAC victory

By Daily Republic staff | From Page: B7

 
Prep baseball: Vanden’s LaGrand tosses shutout at Bethel

By Daily Republic staff | From Page: B7

 
Clippers beat Warriors 98-96 for 2-1 series lead

By The Associated Press | From Page: B7 | Gallery

LA Kings avoid elimination in 6-3 win over Sharks

By The Associated Press | From Page: B7 | Gallery

 
JC baseball: Solano’s late rally falls short in 6-5 loss to Marin

By Daily Republic staff | From Page: B7 | Gallery

Fairfield Expos announce schedule for 2014 season

By Paul Farmer | From Page: B8

 
Silver: Premature to say union will opt out of CBA

By The Associated Press | From Page: B8

Cal Poly baseball team is toast of the West Coast

By The Associated Press | From Page: B8

 
Michael Phelps loses to Lochte in comeback meet

By The Associated Press | From Page: B8 | Gallery

Northwestern players to cast historic union vote

By The Associated Press | From Page: B9

 
Pineda not only pitcher in majors to try pine tar

By The Associated Press | From Page: B9

Pineda banned 10 games for pine tar, won’t appeal

By The Associated Press | From Page: B9 | Gallery

 
.

Business

4Runner keeps rugged charm

By Ann M. Job | From Page: C1

 
Audi’s RS 7 is answer to Porsche, Mercedes

By Ann M. Job | From Page: C2

US proposes pay-for-priority Internet standards

By The Associated Press | From Page: B11

 
Google, Apple settle high-tech workers’ lawsuit

By The Associated Press | From Page: B11

Amazon launches grocery service for Prime members

By The Associated Press | From Page: B11

 
Wireless industry makes anti-theft commitment

By The Associated Press | From Page: B11

.

Obituaries

Robert James Carty Sr.

By Nancy Green | From Page: A4

 
Jean Sophia Ruckdeschel

By Nancy Green | From Page: A4

Judith Catherine Brooks

By Nancy Green | From Page: A4

 
.

Comics

Pickles

By Daily Republic Syndicated Content | From Page: A8

 
Rose is Rose

By Daily Republic Syndicated Content | From Page: A8

Peanuts

By Daily Republic Syndicated Content | From Page: A8

 
Blondie

By Daily Republic Syndicated Content | From Page: A8

Baby Blues

By Daily Republic Syndicated Content | From Page: A8

 
Garfield

By Daily Republic Syndicated Content | From Page: A8

Beetle Bailey

By Daily Republic Syndicated Content | From Page: A8

 
Sally Forth

By Daily Republic Syndicated Content | From Page: A8

Zits

By Daily Republic Syndicated Content | From Page: A8

 
For Better or Worse

By Daily Republic Syndicated Content | From Page: A8

B.C.

By Daily Republic Syndicated Content | From Page: A8

 
Wizard Of Id

By Daily Republic Syndicated Content | From Page: A8

Get Fuzzy

By Daily Republic Syndicated Content | From Page: A8

 
Baldo

By Daily Republic Syndicated Content | From Page: A8

Dilbert

By Daily Republic Syndicated Content | From Page: A8

 
Frank and Ernest

By Daily Republic Syndicated Content | From Page: A8

Cryptoquote

By Daily Republic Syndicated Content | From Page: A9

 
Crossword

By Daily Republic Syndicated Content | From Page: A9

Word Sleuth

By Daily Republic Syndicated Content | From Page: A9

 
Bridge

By Daily Republic Syndicated Content | From Page: A9

Sudoku

By Daily Republic Syndicated Content | From Page: A9